Novel dual immunotherapy for the treatment of drug-resistant ovarian cancer, with a disease control rate of 67% 12/07/2023
Application of Talazoparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene changes 21/06/2022 prostate cancer
Precision treatment of triple-negative breast cancer | Gosatuzumab research data –HKUOC 21/06/2022 breast cancer
Triple-negative breast cancer survival significantly improved! Cosela receives FDA Fast Track designation. 21/06/2022 breast cancer
